Forgot to also add,“We are planning to reformulate Exenatide and target a number of different diseases that involve increased brain pressure,” Mr McAuliffe said.
“Over 10 years of research has gone into this project prior to the IPO and numerous papers have been published in prestigious medical journals around all the work to date,” he added.
Clearly the directors believe in their project and their potential in becoming a billion dollar bio firm by being responsible for the global treatment of IIH. The people on board, the substantial evidences to date linking Exenetide for the treamtent of IIH truly makes me believe...
- Forums
- ASX - By Stock
- Ann: Invex Therapeutics Lists on ASX
Forgot to also add,“We are planning to reformulate Exenatide and...
-
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
0.004(5.71%) |
Mkt cap ! $5.561M |
Open | High | Low | Value | Volume |
7.1¢ | 7.5¢ | 7.1¢ | $4.091K | 54.95K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 198734 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 29802 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 198734 | 0.070 |
1 | 10000 | 0.051 |
1 | 200000 | 0.050 |
1 | 60001 | 0.043 |
2 | 510000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.074 | 29802 | 1 |
0.075 | 37000 | 1 |
0.076 | 53829 | 2 |
0.077 | 7950 | 1 |
0.080 | 30000 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online